Literature DB >> 16901949

Voxel-based morphometry of brain SPECT can detect the presence of active central nervous system involvement in systemic lupus erythematosus.

S Appenzeller1, B J Amorim, C D Ramos, P A Rio, E C S de C Etchebehere, E E Camargo, F Cendes, L T L Costallat.   

Abstract

OBJECTIVE: To determine the value of voxel-based morphometry (VBM) of brain SPECT (single-photon emission computed tomography) images (BSI) in discriminating active central nervous system (CNS) manifestations in systemic lupus erythematosus (SLE) patients. PATIENTS AND METHODS: Forty SLE patients (mean age 33 yrs) and 33 normal volunteers were submitted to BSI. SLE patients were screened for the presence of CNS involvement following the American College of Rheumatology (ACR) case definition. Patients with CNS infections, uraemia, diabetes and previous ischaemic or haemorrhagic stroke were excluded. Magnetic resonance imaging (MRI) scans were obtained in a 2T scanner (Elscint Prestige) with T1- and T2-weighted images. BSI were performed after injection of 1110 MBq (30 mCi) of (99m)Tc-ECD (ethyl-cysteinate-dimer). BSI were analysed using the statistical parametric mapping. After normalization, segmentation and smoothing the groups of SLE patients with active and inactive CNS manifestations and healthy volunteers were compared using VBM. Post-processed images were compared voxel-by-voxel using t-test in order to determine differences of intensity between groups. This analysis included grand mean scaling, proportional threshold masking (set to 0.4) and implicit masking. A P-value of 0.001 and cluster size of 32 were taken into consideration.
RESULTS: VBM analyses of BSI did not show any differences between SLE patients with inactive CNS involvement and normal controls. However, the group of SLE patients with active CNS involvement had a global hypoperfusion, more intense in the frontal, dorsolateral and medial temporal lobe when compared with SLE patients without CNS involvement (P = 0.001) and healthy volunteers (P = 0.001).
CONCLUSION: VBM of BSI is a useful and objective method for detecting perfusion abnormalities in SLE patients, which is indicative of active CNS involvement. However, it is not helpful in differentiating the clinical sub-types of CNS involvement according to the ACR classification.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16901949     DOI: 10.1093/rheumatology/kel255

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  11 in total

1.  Localization of cerebral functional deficits in patients with non-neuropsychiatric systemic lupus erythematosus.

Authors:  Yun Lin; Qing-Hua Zou; Jian Wang; Yong Wang; Dai-Quan Zhou; Rong-Hua Zhang; Yan-Wei Zhang; Hai-Tao Lii; Yong-Fei Fang
Journal:  Hum Brain Mapp       Date:  2010-12-17       Impact factor: 5.038

Review 2.  Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management.

Authors:  Mariana Postal; Lilian T L Costallat; Simone Appenzeller
Journal:  CNS Drugs       Date:  2011-09-01       Impact factor: 5.749

Review 3.  Biomarkers for childhood-onset systemic lupus erythematosus.

Authors:  Khalid M Abulaban; Hermine I Brunner
Journal:  Curr Rheumatol Rep       Date:  2015-01       Impact factor: 4.592

4.  Relationship Between Vitamin D Status and Brain Perfusion in Neuropsychiatric Lupus.

Authors:  Nasreen Sultana; Azmal Kabir Sarkar; Hiroshi Matsuda; Md Amimul Ihsan; Syed Atiqul Haq; Md Saidul Arefin; Sheikh Nazrul Islam
Journal:  Nucl Med Mol Imaging       Date:  2022-03-08

Review 5.  Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus.

Authors:  Tony N Marion; Arnold E Postlethwaite
Journal:  Semin Immunopathol       Date:  2014-08-08       Impact factor: 9.623

Review 6.  Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.

Authors:  Hélène Jeltsch-David; Sylviane Muller
Journal:  Nat Rev Neurol       Date:  2014-09-09       Impact factor: 42.937

Review 7.  Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus.

Authors:  Simone Appenzeller; G Bruce Pike; Ann E Clarke
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

Review 8.  Data acquisition and analysis: the strength of methodology in nuclear medicine and molecular imaging.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12       Impact factor: 10.057

9.  Role of Brain Perfusion SPECT with 99mTc HMPAO in the Assessment of Response to Drug Therapy in Patients with Autoimmune Vasculitis: A Prospective Study.

Authors:  Liberatore Mauro; Morreale Manuela; Megna Valentina; Collorone Sara; Sotirios Chondrogiannis; Drudi Francesco Maria; Anagnostou Christos; Civitelli Liana; Francia Ada; Anna Margherita Maffione; Maria Cristina Marzola; Domenico Rubello
Journal:  N Am J Med Sci       Date:  2015-04

10.  Brain Perfusion Impairment in Neurologically Asymptomatic Adult Patients with Sickle-Cell Disease Shown by Voxel-Based Analysis of SPECT Images.

Authors:  Leonardo Deus-Silva; Leonardo Bonilha; Benito P Damasceno; Andre L F Costa; Clarissa L Yasuda; Fernando F Costa; Allan O Santos; Elba C S C Etchebehere; Regis Oquendo-Nogueira; Renata Fockink; Claudio Fróes de Freitas; Edwaldo E Camargo; Li M Li; Fernando Cendes; Sara T Saad
Journal:  Front Neurol       Date:  2013-12-20       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.